You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. ENHANCED DENTAL AMALGAM TRAP

    SBC: ADA TECHNOLOGIES, INC.            Topic: N/A

    DESCRIPTION: Surveys conducted by municipal wastewater treatment plants across the country have concluded that anywhere from 10 percent to over 70 percent of the mercury reaching the plants comes from Dental offices. These findings, combined with increasingly stringent regulations on mercury discharges, have placed pressure on the Dental profession to reduce their dis ...

    SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  2. SELF-DISINFECTING WATERLINE TUBING FOR DENTAL OFFICES

    SBC: ADA TECHNOLOGIES, INC.            Topic: N/A

    DESCRIPTION: The goal of this new SBIR application is to develop an economical Dental waterline that resists biofilm formation and growth. The proposed waterline will utilize a photocatalytic oxidation system to inhibit microbial growth. Such a system would obviate the need for extraneous chemicals and would allow continuous cleansing of the waterlines. The photoreact ...

    SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  3. LUNG DRUG DELIVERY WITH CARBON DIOXIDE AEROSOL INHALERS

    SBC: AEROPHASE, INC.            Topic: N/A

    DESCRIPTION (Adapted from the Investigator's Abstract): The chlorofluorocarbon (CFC) propellants currently being used in metered dose inhalers for pulmonary drug delivery are being phased out due to their high ozone depletion potential. An international pharmaceutical industry consortium has proposed that the zero-ozone depletion potential hydrofluoroalkane (HFA) propel ...

    SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  4. Software Package for Material Model Evaluation

    SBC: APTEK, Inc.            Topic: N/A

    This Phase I and II SBIR will develop a user-friendly, run-time efficient software package dedicated to fitting and evaluating material models used in finite element codes like LS-DYNA. The software package will consist of a pre-processor, a core driver, and a post-processor. The pre-processor will allow the user to specify the material model, model parameters, and desired load history. The dri ...

    SBIR Phase I 2001 Department of Transportation
  5. PEPTIDE FOR GENTLE PURIFICATION OF BIOTINYLATED PROTEIN

    SBC: Avidity, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Affinity tag technology has become increasingly important for immobilizing proteins for high-throughput screening, for generating protein arrays, and for simplifying protein purification. There is a pressing need for economical and technically simple technologies to immobilize or purify proteins. None of the existing molecula ...

    SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  6. LONG-ACTING GM-CSF PROTEINS FOR TREATING NEUTROPENIA

    SBC: BOLDER BIOTECHNOLOGY INC            Topic: N/A

    DESCRIPTION: (Investigator's abstract) Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) is a cytokine that stimulates proliferation and differentiation of hematopoietic progenitor cells. Recombinant human GM-CSF is used to stimulate neutrophil production in patients with neutropenia resulting from myelosuppressive chemotherapy. Recombinant human GMCSF ...

    SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  7. LONG-ACTING GM-CSF PROTEINS FOR TREATING NEUTROPENIA

    SBC: BOLDER BIOTECHNOLOGY INC            Topic: N/A

    DESCRIPTION: (Investigator's abstract) Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) is a cytokine that stimulates proliferation and differentiation of hematopoietic progenitor cells. Recombinant human GM-CSF is used to stimulate neutrophil production in patients with neutropenia resulting from myelosuppressive chemotherapy. Recombinant human GMCSF ...

    SBIR Phase II 2001 Department of Health and Human ServicesNational Institutes of Health
  8. LONG ACTING GCSF PROTEINS FOR TREATING NEUTROPENIA

    SBC: BOLDER BIOTECHNOLOGY INC            Topic: N/A

    DESCRIPTION: This is a Phase II grant application to further develop long acting G-CSF proteins for the treatment of neutropenia. It is submitted by Bolder Biotechnology, Inc. George N. Cox, PhD, Principal investigator. The investigator notes the recombinant G-CSF has a worldwide ...

    SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  9. LONG ACTING GCSF PROTEINS FOR TREATING NEUTROPENIA

    SBC: BOLDER BIOTECHNOLOGY INC            Topic: N/A

    DESCRIPTION: This is a Phase II grant application to further develop long acting G-CSF proteins for the treatment of neutropenia. It is submitted by Bolder Biotechnology, Inc. George N. Cox, PhD, Principal investigator. The investigator notes the recombinant G-CSF has a worldwide ...

    SBIR Phase II 2001 Department of Health and Human ServicesNational Institutes of Health
  10. LONG-ACTING BETA INTERFERON FOR MULTIPLE SCLEROSIS

    SBC: BOLDER BIOTECHNOLOGY INC            Topic: N/A

    Beta-interferon is a fibroblast-derived cytokine that exhibits antiviral, antiproliferative and immunomodulatory effects on many cell types. Recombinant human beta-interferon has proven effective in treating Multiple Sclerosis and had worldwide sales of $850 million during 1998. We propose to create modified beta-interferon proteins that can be administered less frequently, but with greater effica ...

    SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government